NCT03815643 2026-03-31Avelumab Program Rollover StudyEMD SeronoPhase 3 Active not recruiting205 enrolled
NCT04260802 2026-01-12A Study to Evaluate the Safety and Pharmacokinetics of OC-001 in Patients With Locally Advanced or Metastatic CancersOcellaris Pharma, Inc.Phase 1/2 Terminated73 enrolled
NCT04954599 2025-10-07Phase 1/2 Clinical Trial of CP-506 (HAP) in Monotherapy or With Carboplatin or ICIMaastricht University Medical CenterPhase 1/2 Recruiting126 enrolled
NCT03861403 2023-11-30A Dose Escalation and Expansion Study of TRX518 in Combination With Cyclophosphamide Plus Avelumab in Advanced Solid TumorsLeap Therapeutics, Inc.Phase 1 Terminated10 enrolled
NCT01772004 2021-12-20Avelumab in Metastatic or Locally Advanced Solid Tumors (JAVELIN Solid Tumor)EMD SeronoPhase 1 Completed1,756 enrolled 59 charts